Kim P. Kamdar
Domain Associates Partner
investment range
sweet spot
Kim P. Kamdar's Past Investments (17)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Epic Sciences | Series D | $40M | Apr 2017 | |
| ROX Medical | Series E | $40M | Sep 2016 | |
| Syndax Pharmaceuticals | Series C | $80M | Aug 2015 | |
| Sera Prognostics | Series B | $20M | Jan 2015 | |
| Sera Prognostics | Series B | $5M | Nov 2014 | |
| Epic Sciences | Series C | $30M | Jul 2014 | |
| Evofem Biosciences | Series C | $8M | Feb 2014 | |
| Syndax Pharmaceuticals | Series B | $26.6M | Aug 2013 | |
| Evofem Biosciences | Series C | $20.6M | Dec 2012 | |
| Epic Sciences | Series B | $13M (Lead) | Nov 2012 |
Kim P. Kamdar's Experience
Partner Domain Associates - Present
Kim P. Kamdar's Media
No media found for Kim P. Kamdar.